149107-92-6 Usage
Uses
Used in Pharmaceutical Industry:
(3R-cis)-1-Benzoyl-3-(1-methoxy-1-methylethoxy)-4-phenyl-2-azetidinone is used as a potential antitumor agent for its capacity to target and treat cancer cells. Its specific molecular configuration and chemical properties allow it to interact with biological systems in ways that may inhibit tumor growth and proliferation.
Additionally, it is used as a potential anti-inflammatory agent due to its ability to modulate inflammatory responses within the body, which can be beneficial in treating various inflammatory conditions.
(3R-cis)-1-Benzoyl-3-(1-methoxy-1-methylethoxy)-4-phenyl-2-azetidinone's potential applications in drug development are further supported by ongoing research aimed at understanding its mechanisms of action and optimizing its therapeutic efficacy.
Check Digit Verification of cas no
The CAS Registry Mumber 149107-92-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,1,0 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 149107-92:
(8*1)+(7*4)+(6*9)+(5*1)+(4*0)+(3*7)+(2*9)+(1*2)=136
136 % 10 = 6
So 149107-92-6 is a valid CAS Registry Number.
InChI:InChI=1/C20H21NO4/c1-20(2,24-3)25-17-16(14-10-6-4-7-11-14)21(19(17)23)18(22)15-12-8-5-9-13-15/h4-13,16-17H,1-3H3/t16-,17+/m0/s1
149107-92-6Relevant academic research and scientific papers
β-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes
-
Page column 15, (2010/01/30)
Novel β-lactams finding utility as intermediates in the preparation of sidechain-bearing taxanes such as taxol and taxol derivatives. The present invention also relates to novel methods of coupling β-lactams to form such sidechain-bearing taxanes, and to novel sidechain-bearing taxanes.
β-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes
-
Example 3, (2010/01/30)
Novel β-lactams finding utility as intermediates in the preparation of sidechain-bearing taxanes such as taxol and taxol derivatives. The present invention also relates to novel methods of coupling β-lactams to form such sidechain-bearing taxanes, and to
